SNDX
Syndax Pharmaceuticals Inc
17.00$
-2.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.4% | 94.8% | 83.6% | 93.5% | 97.4% | 83.2% | 85.6% | 89.2% | 96.0% | 99.7% | 99.7% | 95.9% | |
| 23.7% | 48.2% | 21.1% | 22.1% | 31.2% | 21.3% | 24.0% | 18.2% | 21.2% | 25.5% | 27.7% | 47.8% | |
| 91.1% | 94.2% | 80.0% | 89.1% | 91.5% | 80.4% | 80.6% | 78.6% | 82.3% | 74.4% | 74.5% | 77.9% | |
| 1.1% | 0.2% | 1.4% | 2.3% | 1.1% | 1.9% | 3.4% | 6.3% | 7.8% | 7.2% | 12.8% | 10.0% | |
| 0.7% | 0.3% | – | – | -1.1% | 0.1% | 0.7% | 3.0% | 4.5% | 6.2% | 7.4% | 4.7% | |
| 10.0% | 9.6% | 9.4% | 8.9% | 13.9% | 60.2% | 66.4% | 73.6% | 79.1% | 87.8% | 91.2% | 97.9% | |
| 9.8% | 9.5% | 9.4% | 8.9% | 13.9% | 14.3% | 14.8% | 19.0% | 20.7% | 22.7% | 18.2% | 14.2% | |
| 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 1.7% | 0.1% | 0.1% | 4.2% | 0.1% | 0.1% | 0.1% | |
| 1.5% | 2.8% | 1.6% | 2.4% | 1.2% | 1.6% | 1.6% | 2.9% | 2.5% | 3.1% | 2.3% | 0.7% | |
| – | – | – | – | – | 45.7% | – | – | – | 64.9% | 72.8% | 83.6% | |
| 90.0% | 90.4% | 90.6% | 91.1% | 86.1% | 39.8% | 33.6% | 26.4% | 20.9% | 12.2% | 8.8% | 2.1% | |
| -207.9% | -147.2% | -179.5% | -218.7% | -264.7% | -168.5% | -203.8% | -231.1% | -260.7% | -284.4% | -327.8% | -227.2% | |
| 17.5% | 11.8% | 15.7% | 17.9% | 20.1% | 11.8% | 13.4% | 14.5% | 15.7% | 16.4% | 18.3% | 12.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.